Search for Covered Drugs
CCA covers a wide range of both over-the-counter and brand-name and generic prescription drugs. Use the links below to search our formulary, drugs that require prior authorization or step therapy for each CCA Rhode Island plan.
Submit Prior Authorization Form Online
Submit a prior authorization request for prescription drug coverage determination online, or through mail or fax using the form below:
Medicare Part B vs. D Forms
Prior authorization is required to determine appropriate coverage under Medicare Part B or Part D.
To initiate a Medicare Part B vs. D coverage determination request, please use the following method:
Call Navitus MedicareRx Customer Care at 1-866-270-3877. The Customer Care Agent can complete the questions on Navitus’ internal Primary Billing Form and complete the Part B vs. Part D request, allowing for an immediate determination over the phone.
- Anti-Rejection Drugs, Immunosuppressants
- ESRD/Dialysis-Related Drugs
- Immune Globulins
- Infusion/Injectable Drugs
- Nebulized Medications
- Oral Anti-Emetic Drugs
- Oral Chemotherapy Agents
- TPN / IDPN / IPN
- Treprostinil (TYVASO)
Navitus Health Solutions will review your request and make a determination as to whether the request meets the requirements for approval. The decisions for standard requests are made no later than 72 hours from when we received the request. If waiting 72 hours could potentially jeopardize a patient’s health, providers can send an expedited request for the patient, in which case a decision will be issued within 24 hours. For all expedited requests, providers must include a statement that they confirm that this request should be escalated.
If the request is denied, patients or their provider have the right to appeal our decision.
CCA Redetermination Form
If your request for coverage for a prescription drug was denied, you have the right to ask for an appeal of our decision within 60 days of the Notice of Denial.
The Prescriber Portal allows providers to access claim status, member eligibility, and claim submission options.
We’re here to help.